Feedback / Questions
LiPlaCis (liposomal cisplatin) - Oncology Venture
dovitinib (TKI258)
Lenvima (lenvatinib) - Eisai, Merck (MSD)
Keytruda (pembrolizumab) - Merck (MSD)
http://www.globenewswire.com/news-release/2019/04/03/1795884/0/sv/Oncology-Venture-har-bekr%C3%A4ftat-registreringsstrategin-f%C3%B6r-dovitinib-och-utvecklat-ny-DRP-kombinationsbiomark%C3%B6r-f%C3%B6r-PD1-PD-L1-dovitinib-inleder-utlicensieringsaktiviteter-med-Destum.html
Apr 2, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next